Transient receptor potential cation 3 channel regulates melanoma proliferation and migration

被引:34
作者
Oda, Kayoko [1 ,2 ]
Umemura, Masanari [1 ]
Nakakaji, Rina [1 ]
Tanaka, Ryo [1 ]
Sato, Itaru [1 ]
Nagasako, Akane [1 ]
Oyamada, Chiaki [1 ]
Baljinnyam, Erdene [3 ]
Katsumata, Mayumi [1 ]
Xie, Lai-Hua [3 ]
Narikawa, Masatoshi [1 ]
Yamaguchi, Yukie [2 ]
Akimoto, Taisuke [1 ]
Ohtake, Makoto [1 ]
Fujita, Takayuki [1 ]
Yokoyama, Utako [1 ]
Iwatsubo, Kousaku [1 ,4 ]
Aihara, Michiko [2 ]
Ishikawa, Yoshihiro [1 ]
机构
[1] Yokohama City Univ, Sch Med, Cardiovasc Res Inst, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan
[2] Yokohama City Univ, Sch Med, Dept Environm Immunedermatol, Yokohama, Kanagawa, Japan
[3] Rutgers State Univ, Dept Cell Biol & Mol Med, New Jersey Med Sch, Newark, NJ USA
[4] South Miyazaki Kidney Clin, Miyazaki, Japan
基金
日本学术振兴会;
关键词
TRPC3; Proliferation; Migration; Melanoma; Metastasis; Pyr3; CELL MIGRATION; CA2+ ENTRY; SURVIVAL; DELIVERY; STORE; TRPC3; SRC;
D O I
10.1007/s12576-016-0480-1
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Melanoma has an extremely poor prognosis due to its rapidly progressive and highly metastatic nature. Several therapeutic drugs have recently become available, but are effective only against melanoma with specific BRAF gene mutation. Thus, there is a need to identify other target molecules. We show here that Transient receptor potential, canonical 3 (TRPC3) is widely expressed in human melanoma. We found that pharmacological inhibition of TRPC3 with a pyrazole compound, Pyr3, decreased melanoma cell proliferation and migration. Similar inhibition was observed when the TRPC3 gene was silenced with short-hairpin RNA (shRNA). Pyr3 induced dephosphorylation of signal transducer and activator of transcription (STAT) 5 and Akt. Administration of Pyr3 (0.05 mg/kg) to mice implanted with human melanoma cells (C8161) significantly inhibited tumor growth. Our findings indicate that TRPC3 plays an important role in melanoma growth, and may be a novel target for treating melanoma in patients.
引用
收藏
页码:497 / 505
页数:9
相关论文
共 24 条
[1]   Abnormal expression, localization and interaction of canonical transient receptor potential ion channels in human breast cancer cell lines and tissues: a potential target for breast cancer diagnosis and therapy [J].
Aydar, Ebru ;
Yeo, Syn ;
Djamgoz, Mustafa ;
Palmer, Christopher .
CANCER CELL INTERNATIONAL, 2009, 9
[2]   Epac1 increases migration of endothelial cells and melanoma cells via FGF2-mediated paracrine signaling [J].
Baljinnyam, Erdene ;
Umemura, Masanari ;
Chuang, Christine ;
De Lorenzo, Mariana S. ;
Iwatsubo, Mizuka ;
Chen, Suzie ;
Goydos, James S. ;
Ishikawa, Yoshihiro ;
Whitelock, John M. ;
Iwatsubo, Kousaku .
PIGMENT CELL & MELANOMA RESEARCH, 2014, 27 (04) :611-620
[3]   Epac1 promotes melanoma metastasis via modification of heparan sulfate [J].
Baljinnyam, Erdene ;
Umemura, Masanari ;
De Lorenzo, Mariana S. ;
Iwatsubo, Mizuka ;
Chen, Suzie ;
Goydos, James S. ;
Iwatsubo, Kousaku .
PIGMENT CELL & MELANOMA RESEARCH, 2011, 24 (04) :680-687
[4]   Exchange Protein Directly Activated by Cyclic AMP Increases Melanoma Cell Migration by a Ca2+-Dependent Mechanism [J].
Baljinnyam, Erdene ;
De Lorenzo, Mariana S. ;
Xie, Lai-Hua ;
Iwatsubo, Mizuka ;
Chen, Suzie ;
Goydos, James S. ;
Nowycky, Martha C. ;
Iwatsubo, Kousaku .
CANCER RESEARCH, 2010, 70 (13) :5607-5617
[5]   Epac increases melanoma cell migration by a heparan sulfate-related mechanism [J].
Baljinnyam, Erdene ;
Iwatsubo, Kousaku ;
Kurotani, Reiko ;
Wang, Xu ;
Ulucan, Coskun ;
Iwatsubo, Mizuka ;
Lagunoff, David ;
Ishikawa, Yoshihiro .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2009, 297 (04) :C802-C813
[6]   Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation [J].
Chapman, Paul B. ;
Hauschild, Axel ;
Robert, Caroline ;
Haanen, John B. ;
Ascierto, Paolo ;
Larkin, James ;
Dummer, Reinhard ;
Garbe, Claus ;
Testori, Alessandro ;
Maio, Michele ;
Hogg, David ;
Lorigan, Paul ;
Lebbe, Celeste ;
Jouary, Thomas ;
Schadendorf, Dirk ;
Ribas, Antoni ;
O'Day, Steven J. ;
Sosman, Jeffrey A. ;
Kirkwood, John M. ;
Eggermont, Alexander M. M. ;
Dreno, Brigitte ;
Nolop, Keith ;
Li, Jiang ;
Nelson, Betty ;
Hou, Jeannie ;
Lee, Richard J. ;
Flaherty, Keith T. ;
McArthur, Grant A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (26) :2507-2516
[7]   Targeted Therapy Resistance Mechanisms and Therapeutic Implications in Melanoma [J].
Chen, Guo ;
Davies, Michael A. .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2014, 28 (03) :523-+
[8]   A magnetic anti-cancer compound for magnet-guided delivery and magnetic resonance imaging [J].
Eguchi, Haruki ;
Umemura, Masanari ;
Kurotani, Reiko ;
Fukumura, Hidenobu ;
Sato, Itaru ;
Kim, Jeong-Hwan ;
Hoshino, Yujiro ;
Lee, Jin ;
Amemiya, Naoyuki ;
Sato, Motohiko ;
Hirata, Kunio ;
Singh, David J. ;
Masuda, Takatsugu ;
Yamamoto, Masahiro ;
Urano, Tsutomu ;
Yoshida, Keiichiro ;
Tanigaki, Katsumi ;
Yamamoto, Masaki ;
Sato, Mamoru ;
Inoue, Seiichi ;
Aoki, Ichio ;
Ishikawa, Yoshihiro .
SCIENTIFIC REPORTS, 2015, 5
[9]   Lipid rafts couple store-operated Ca2+ entry to constitutive activation of PKB/Akt in a Ca2+/calmodulin-, Src- and PP2A-mediated pathway and promote melanoma tumor growth [J].
Fedida-Metula, Shlomit ;
Feldman, Ben ;
Koshelev, Valeria ;
Levin-Gromiko, Uliana ;
Voronov, Elena ;
Fishman, Daniel .
CARCINOGENESIS, 2012, 33 (04) :740-750
[10]   Involvement of TRPC Channels in Lung Cancer Cell Differentiation and the Correlation Analysis in Human Non-Small Cell Lung Cancer [J].
Jiang, Hong-Ni ;
Zeng, Bo ;
Zhang, Yi ;
Daskoulidou, Nikoleta ;
Fan, Hong ;
Qu, Jie-Ming ;
Xu, Shang-Zhong .
PLOS ONE, 2013, 8 (06)